approval · primary record
APIXABAN
FDA · NDA · 2026-06-24
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-06-24 |
| Brand | ELIQUIS |
| Sponsor | BRISTOL |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:10.566Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:APIXABAN:2026-06-24
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.